Marker Therapeutics is trading 9.65% up at $1.25 after rising from the August 5 close of $1.14, with no clear company-specific catalyst identified.
- No fresh company-specific announcement, filing, earnings release, or analyst action explaining the August 6 move was identified; market pages showed no current headlines or press releases.
- Broader markets are mixed rather than strongly supportive.
- The move appears idiosyncratic and likely reflects thin micro-cap trading; confidence remains low pending possible delayed news.